Cary N. Robertson

11.3k total citations · 2 hit papers
132 papers, 8.1k citations indexed

About

Cary N. Robertson is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Cary N. Robertson has authored 132 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Pulmonary and Respiratory Medicine, 34 papers in Surgery and 25 papers in Oncology. Recurrent topics in Cary N. Robertson's work include Prostate Cancer Diagnosis and Treatment (62 papers), Prostate Cancer Treatment and Research (59 papers) and Urologic and reproductive health conditions (18 papers). Cary N. Robertson is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (62 papers), Prostate Cancer Treatment and Research (59 papers) and Urologic and reproductive health conditions (18 papers). Cary N. Robertson collaborates with scholars based in United States, France and United Kingdom. Cary N. Robertson's co-authors include Thomas J. Polascik, W. Marston Linehan, Alfred E. Chang, Claudia A. Seipp, Michael T. Lotze, Steven A. Rosenberg, Donald E. White, Susan F. Leitman, Colleen Simpson and Joshua T. Rubin and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Cary N. Robertson

129 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

1987 2.2k citations Cary N. Robertson et al. profile →
Genetic Risk and Carcinogen Exposure: a Common Inherited Defect of the Carcinogen-Metabolism Gene Glutathione S-Transferase M1 (GSTM1) That Increases Susceptibility to Bladder Cancer

1993 599 citations David F. Paulson, Cary N. Robertson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cary N. Robertson United States	42	3.1k	2.3k	1.8k	1.8k	1.3k	132	8.1k
Chikara Οhyama Japan	43	2.6k 0.8×	2.2k 0.9×	1.5k 0.8×	3.5k 2.0×	3.0k 2.2×	524	9.3k
Brent A. Blumenstein United States	40	5.6k 1.8×	3.9k 1.7×	1.4k 0.8×	2.8k 1.6×	3.2k 2.4×	123	12.0k
Masaru Murai Japan	44	2.7k 0.9×	1.3k 0.6×	546 0.3×	2.4k 1.3×	1.3k 1.0×	234	6.5k
Diana Giannarelli Italy	54	3.6k 1.2×	6.6k 2.9×	1.9k 1.0×	1.8k 1.0×	2.5k 1.9×	604	13.2k
Henrik Grönberg Sweden	57	5.2k 1.7×	2.6k 1.1×	950 0.5×	3.2k 1.8×	1.1k 0.8×	263	11.6k
Pierluigi Benedetti Panici Italy	63	1.2k 0.4×	3.6k 1.6×	1.4k 0.7×	2.8k 1.6×	3.9k 2.9×	566	16.0k
Vesa Kataja Finland	49	2.1k 0.7×	4.0k 1.7×	688 0.4×	2.5k 1.4×	1.6k 1.2×	176	9.1k
William C. DeWolf United States	43	2.2k 0.7×	672 0.3×	655 0.4×	1.7k 1.0×	1.3k 1.0×	145	6.0k
Alicia Samuels United States	8	3.5k 1.1×	4.7k 2.1×	617 0.3×	3.4k 1.9×	2.1k 1.6×	8	11.4k
Taylor Murray United States	6	3.3k 1.1×	4.5k 2.0×	674 0.4×	3.8k 2.1×	2.0k 1.5×	7	11.5k

Countries citing papers authored by Cary N. Robertson

Since Specialization

Citations

This map shows the geographic impact of Cary N. Robertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cary N. Robertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cary N. Robertson more than expected).

Fields of papers citing papers by Cary N. Robertson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cary N. Robertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cary N. Robertson. The network helps show where Cary N. Robertson may publish in the future.

Co-authorship network of co-authors of Cary N. Robertson

This figure shows the co-authorship network connecting the top 25 collaborators of Cary N. Robertson. A scholar is included among the top collaborators of Cary N. Robertson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cary N. Robertson. Cary N. Robertson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kotamarti, Srinath, Alireza Ghoreifi, Cary N. Robertson, et al.. (2025). External validation of inter-reader reliability of the Prostate Imaging after Focal Ablation (PI-FAB) scoring system following focal cryoablation and focal high-intensity focused ultrasound. European Radiology. 35(11). 7004–7012. 1 indexed citations

Bakavičius, Arnas, Giancarlo Marra, Petr Macek, et al.. (2022). Available evidence on HIFU for focal treatment of prostate cancer: a systematic review. International braz j urol. 48(2). 263–274. 36 indexed citations

Ranby, Krista W., et al.. (2019). Illness uncertainty, partner support, and quality of life: A dyadic longitudinal investigation of couples facing prostate cancer. Psycho-Oncology. 28(11). 2188–2194. 25 indexed citations

Muller, Berrend G., Jurgen J. Fütterer, Rajan T. Gupta, et al.. (2013). The role of magnetic resonance imaging ( MRI ) in focal therapy for prostate cancer: recommendations from a consensus panel. British Journal of Urology. 113(2). 218–227. 69 indexed citations

Wattson, Daniel A., Ming‐Hui Chen, Judd W. Moul, et al.. (2012). The Number of High-Risk Factors and the Risk of Prostate Cancer–Specific Mortality After Brachytherapy: Implications for Treatment Selection. International Journal of Radiation Oncology*Biology*Physics. 82(5). e773–e779. 17 indexed citations

Sun, Leon, Peng Tang, Cary N. Robertson, et al.. (2010). Predicting non-organ-confined prostate cancer in men diagnosed after 2000. Prostate Cancer and Prostatic Diseases. 13(3). 248–251. 6 indexed citations

D’Amico, Anthony V., Ming‐Hui Chen, Leon Sun, et al.. (2010). Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death. British Journal of Urology. 106(11). 1618–1622. 24 indexed citations

Tang, Ping, Leon Sun, Matthew A. Uhlman, et al.. (2010). Prostate‐specific antigen velocity based risk‐adapted discontinuation of prostate cancer screening in elderly men. British Journal of Urology. 108(1). 44–48. 4 indexed citations

Uhlman, Matthew A., Leon Sun, Thomas J. Polascik, et al.. (2009). Tumor Volume, Tumor Percentage Involvement, or Prostate Volume: Which Is Predictive of Prostate-specific Antigen Recurrence?. Urology. 75(2). 460–466. 31 indexed citations

10.

Price, Marva M., et al.. (2008). Body Mass Index, Prostate-Specific Antigen, and Digital Rectal Examination Findings Among Participants in a Prostate Cancer Screening Clinic. Urology. 71(5). 787–791. 39 indexed citations

11.

Sun, Leon, Kevin C. Zorn, David Albala, et al.. (2008). PRE-TREATMENT FACTORS PREDICTIVE OF POSITIVE SURGICAL MARGIN IN CONTEMPORARY RADICAL PROSTATECTOMIES. The Journal of Urology. 179(4S). 250–250. 1 indexed citations

12.

Price, David T., et al.. (2002). Comparison of [18F]Fluorocholine and [18F]Fluorodeoxyglucose for Positron Emission Tomography of Androgen Dependent and Androgen Independent Prostate Cancer. The Journal of Urology. 273–280. 10 indexed citations

13.

Ahearn, Gregory S., Richard Bedlack, David T. Price, Cary N. Robertson, & Joel C. Morgenlander. (1999). Transient Lumbosacral Polyradiculopathy After Prostatectomy. Southern Medical Journal. 92(8). 809–811. 1 indexed citations

14.

Padilla‐Nash, Hesed, William G. Nash, George M. Padilla, et al.. (1999). Molecular cytogenetic analysis of the bladder carcinoma cell line BK-10 by spectral karyotyping. Genes Chromosomes and Cancer. 25(1). 53–59. 36 indexed citations

15.

Yancey, Donna, Hesed Padilla‐Nash, William Nash, et al.. (1998). Isolation and characterization of a novel human bladder cancer cell line: BK10. In Vitro Cellular & Developmental Biology - Animal. 34(7). 537–544. 4 indexed citations

16.

Demark‐Wahnefried, Wendy, Mark R. Conaway, Cary N. Robertson, et al.. (1997). Anthropometric risk factors for prostate cancer. Nutrition and Cancer. 28(3). 302–307. 35 indexed citations

17.

Dodd, Leslie G., William W. Johnston, Cary N. Robertson, & Lester J. Layfield. (1997). Endoscopic Brush Cytology of the Upper Urinary Tract. Acta Cytologica. 41(2). 377–384. 33 indexed citations

18.

Robertson, Cary N. & David F. Paulson. (1991). DNA in Radical Prostatectomy Specimens: Prognostic Value of Tumor Ploidy. Acta Oncologica. 30(2). 205–207. 4 indexed citations

19.

Robertson, Cary N. & David F. Paulson. (1991). Radical Surgery Versus Radiation Therapy in Early Prostatic Carcinoma. Acta Oncologica. 30(2). 239–242. 4 indexed citations

20.

Ashby, Helen, et al.. (1989). The Inhibition of Human Adrenal Steroidogenic Enzyme Activities by Suramin*. The Journal of Clinical Endocrinology & Metabolism. 68(2). 505–508. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact